Form 4 for MRK Merck & Co.
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-04 · accession 0001127602-24-014263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-06 | 2024-05-04 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | F - Tax | $127.51 | -450 | 23.8K | -2% | -$57.4K |
| D | 2024-05-06 | 2024-05-04 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $127.51 | +912 | 24.3K | +4% | +$116.3K |
| D | 2024-05-06 | 2024-05-04 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $0.00 | -912 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-04 | F | D | 450 | $127.51 | 23,820.95 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 2 | Common | Common Stock | 2024-05-04 | M | A | 912 | $127.51 | 24,270.95 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-05-04 | M | D | 912 | $0.00 | 0 | D | — · 2022-05-04 to 2024-05-04 | 912 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. |